RARE
Ultragenyx Pharmaceutical Inc. · Healthcare
Chief Financial Officer Howard Horn sold $108K of Ultragenyx Pharmaceutical Inc.
Sold$107,898
$15.27Price
7,066Shares
−7%Stake
What RARE did after the filing
- The stock from Mon, Oct 19 close, $15.07
- +6.3%
- S&P 500, same days
- +0.3%
1 of 30 trading days so far, to the Oct 20 close.
Traded Thu, Oct 15. Filed Mon, Oct 19, 1:48 PM ET, during the session. Returns use the Oct 19 close and the Oct 20 close. Not investment advice.